Olivier Brandicourt is to retire as chief executive of Sanofi SA and be replaced by 51-year-old Paul Hudson, head of Novartis Pharmaceuticals. Mr Hudson will take up his position on 1 September marking the third change in Sanofi’s top leadership in a little more than a year.
